Subtle vitamin-B12 deficiency and psychiatry: a largely unnoticed but devastating relationship?

Area of Science:

• Neurology
• Psychiatry
• Nutritional Science

Background:

• Vitamin B12 deficiency is linked to various psychiatric and neurological disorders.
• Current understanding may underestimate the prevalence of B12 deficiency as a cause of these conditions.
• Cerebral manifestations of B12 deficiency are often overlooked due to a lack of awareness regarding necessary serum B12 levels.

Purpose of the Study:

• To investigate the potential underdiagnosis of vitamin B12 deficiency in psychiatric disorders.
• To highlight the importance of serum B12 levels in preventing cognitive and mood-related symptoms.
• To review and clarify diagnostic and treatment myths associated with B12 deficiency.

Main Methods:

• Literature review and extrapolation from reputable published sources.
• Analysis of the role of vitamin B12 in mood disorders, paranoid psychoses, and dementia.
• Examination of diagnostic criteria and treatment efficacy for B12 deficiency.

Main Results:

• Psychiatric conditions, including mood disorders, dementia, and paranoid psychoses, are frequently associated with vitamin B12 deficiency.
• Lower-than-appreciated serum B12 levels may be sufficient to cause cerebral manifestations.
• Myths surrounding high-dose oral treatment and the diagnostic limitations of the Schilling test were addressed.

Conclusions:

• Vitamin B12 deficiency is a potentially underestimated cause of psychiatric and neurological symptoms.
• Accurate assessment of serum B12 levels is crucial for diagnosing and managing these conditions.
• Rethinking diagnostic approaches and treatment strategies for B12 deficiency is warranted.